Ligand-supported homology modeling of G-protein-coupled receptor sites: Models sufficient for successful virtual screening

被引:82
作者
Evers, A [1 ]
Klebe, G [1 ]
机构
[1] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
关键词
computer chemistry; G proteins; protein models; receptors;
D O I
10.1002/anie.200352776
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Virtual proteins: A computer method is described that uses ligand information in the homology modeling of proteins. This method was used to construct a model of a G-protein-coupled receptor, which was successfully used as a basis for structure-based drug design by virtual computer screening (see picture).
引用
收藏
页码:248 / 251
页数:4
相关论文
共 31 条
[1]   Protein structure prediction and structural genomics [J].
Baker, D ;
Sali, A .
SCIENCE, 2001, 294 (5540) :93-96
[2]  
Ballesteros JA, 1995, Methods Neurosci, V25, P366, DOI [DOI 10.1016/S1043-9471(05)80049-7, 10.1016/S1043-9471(05)80049-7]
[3]  
Becker OM, 2003, CURR OPIN DRUG DISC, V6, P353
[4]   Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? [J].
Bissantz, C ;
Bernard, P ;
Hibert, M ;
Rognan, D .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (01) :5-25
[5]   Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structures [J].
Boks, GJ ;
Tollenaere, JP ;
Kroon, J .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (03) :535-547
[6]   Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis [J].
Brenk, R ;
Naerum, L ;
Grädler, U ;
Gerber, HD ;
Garcia, GA ;
Reuter, K ;
Stubbs, MT ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1133-1143
[7]   Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials [J].
Evers, A ;
Gohlke, H ;
Klebe, G .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 334 (02) :327-345
[8]   Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II [J].
Flohr, S ;
Kurz, M ;
Kostenis, E ;
Brkovich, A ;
Fournier, A ;
Klabunde, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) :1799-1805
[9]  
FONG TM, 1994, J BIOL CHEM, V269, P2728
[10]  
FONG TM, 1994, J BIOL CHEM, V269, P14957